Clinical Trial Update: Efficacy and Tolerability of Entospletinib in Combination With Systemic Corticosteroids as First-Line Therapy in Adults With Chronic Graft Versus Host Disease (cGVHD) [Phase 2]

View source ↗

Summary

Phase 2 trial investigating entospletinib with systemic corticosteroids as first-line therapy for chronic graft-versus-host disease; study terminated with resul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease

Drugs mentioned

• Entospletinib (entospletinib)

Snippet

Sponsor: Gilead Sciences | Conditions: Chronic Graft Versus Host Disease | Phase 2 | Status: TERMINATED | Results posted: 2018-12-26